Shares

34 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 15, 2022

SELL
$1.36 - $2.94 $15,965 - $34,512
-11,739 Closed
0 $0
Q3 2021

May 17, 2024

SELL
$2.97 - $4.84 $68,506 - $111,639
-23,066 Reduced 66.27%
11,739 $35,000
Q3 2021

Jun 21, 2023

BUY
$2.97 - $4.84 $34,864 - $56,816
11,739 New
11,739 $35,000
Q3 2021

Mar 22, 2023

SELL
$2.97 - $4.84 $68,506 - $111,639
-23,066 Reduced 66.27%
11,739 $35,000
Q3 2021

Nov 15, 2021

SELL
$2.97 - $4.84 $68,506 - $111,639
-23,066 Reduced 66.27%
11,739 $35,000
Q2 2021

May 17, 2024

BUY
$3.71 - $5.13 $112,398 - $155,418
30,296 Added 671.9%
34,805 $160,000
Q2 2021

Jun 21, 2023

BUY
$3.71 - $5.13 $129,126 - $178,549
34,805 New
34,805 $160,000
Q2 2021

Mar 22, 2023

BUY
$3.71 - $5.13 $112,398 - $155,418
30,296 Added 671.9%
34,805 $160,000
Q2 2021

Aug 16, 2021

BUY
$3.71 - $5.13 $112,398 - $155,418
30,296 Added 671.9%
34,805 $161,000
Q1 2021

May 17, 2024

BUY
$4.08 - $14.75 $18,396 - $66,507
4,509 New
4,509 $19,000
Q1 2021

Jun 26, 2023

BUY
$4.08 - $14.75 $18,396 - $66,507
4,509 New
4,509 $19.4 Million
Q1 2021

Mar 22, 2023

SELL
$4.08 - $14.75 $104,566 - $378,027
-25,629 Reduced 85.04%
4,509 $19,000
Q1 2021

May 14, 2021

SELL
$4.08 - $14.75 $104,566 - $378,027
-25,629 Reduced 85.04%
4,509 $19,000
Q4 2020

May 24, 2024

SELL
$11.06 - $14.01 $10,993 - $13,925
-994 Reduced 3.19%
30,138 $333,000
Q4 2020

Jun 22, 2023

BUY
$11.06 - $14.01 $333,326 - $422,233
30,138 New
30,138 $333,000
Q4 2020

Mar 22, 2023

SELL
$11.06 - $14.01 $10,993 - $13,925
-994 Reduced 3.19%
30,138 $333,000
Q4 2020

Feb 16, 2021

SELL
$11.06 - $14.01 $10,993 - $13,925
-994 Reduced 3.19%
30,138 $333,000
Q3 2020

Jun 26, 2023

BUY
$10.26 - $14.55 $319,414 - $452,970
31,132 New
31,132 $376,000
Q2 2020

May 24, 2024

BUY
$7.11 - $13.76 $221,348 - $428,376
31,132 New
31,132 $428 Million
Q2 2020

Jun 26, 2023

BUY
$7.11 - $13.76 $221,348 - $428,376
31,132 New
31,132 $428,000
Q1 2020

Jul 12, 2023

BUY
$5.71 - $15.85 $177,763 - $493,442
31,132 New
31,132 $240,000
Q4 2019

Jul 12, 2023

BUY
$9.6 - $17.75 $298,867 - $552,593
31,132 New
31,132 $475,000
Q3 2019

Jul 12, 2023

BUY
$12.16 - $21.0 $378,565 - $653,772
31,132 New
31,132 $378,000
Q3 2019

Mar 22, 2023

BUY
$12.16 - $21.0 $133,285 - $230,181
10,961 Added 54.34%
31,132 $378,000
Q3 2019

Nov 14, 2019

BUY
$12.16 - $21.0 $133,285 - $230,181
10,961 Added 54.34%
31,132 $379,000
Q2 2019

Jul 12, 2023

BUY
$9.44 - $19.8 $258,976 - $543,193
27,434 New
27,434 $543,000
Q1 2019

Jul 13, 2023

BUY
$11.11 - $13.49 $224,099 - $272,106
20,171 New
20,171 $247,000
Q4 2018

Jul 13, 2023

BUY
$10.24 - $15.49 $206,551 - $312,448
20,171 New
20,171 $255,000
Q4 2018

Mar 22, 2023

SELL
$10.24 - $15.49 $113,920 - $172,326
-11,125 Reduced 35.55%
20,171 $255,000
Q4 2018

Feb 14, 2019

SELL
$10.24 - $15.49 $113,920 - $172,326
-11,125 Reduced 35.55%
20,171 $256,000
Q3 2018

Jul 13, 2023

BUY
$15.53 - $19.97 $313,255 - $402,814
20,171 New
20,171 $313,000
Q3 2018

Mar 22, 2023

BUY
$15.53 - $19.97 $486,026 - $624,981
31,296 New
31,296 $486,000
Q3 2018

Nov 14, 2018

BUY
$15.53 - $19.97 $172,771 - $222,166
11,125 Added 55.15%
31,296 $486,000
Q2 2018

Aug 15, 2018

BUY
$15.88 - $19.5 $320,315 - $393,334
20,171 New
20,171 $376,000

Others Institutions Holding ATNX

About Athenex, Inc.


  • Ticker ATNX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 156,790,000
  • Market Cap $1.57M
  • Description
  • Athenex, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of drugs for the treatment of cancer. It operates through three segments: Oncology Innovation Platform, Global Supply Chain Platform, and Commercial Platform. The company's Orascovery product candidates include Oral paclitaxel and encequidar,...
More about ATNX
Track This Portfolio

Track Met Life Investment Management, LLC Portfolio

Follow Met Life Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Met Life Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Met Life Investment Management, LLC with notifications on news.